Advertisement
Advertisement

LQDA

LQDA logo

Liquidia Corporation Common Stock

14.18
USD
+0.67
+4.92%
Apr 30, 15:05 UTC -4
Open

Liquidia Corporation Common Stock Profile

About

Liquidia Technologies, Inc. is a late-stage clinical biopharmaceutical company. It focused on the development and commercialization of human therapeutics using our proprietary PRINT technology to transform the lives of patients. The company's product candidate consists of LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain which are in clinical stage. Liquidia Technologies, Inc. is based in NC, United States.

Info & Links

CEO

Roger A. Jeffs

Headquarters

419 DAVIS DRIVE, SUITE 100
MORRISVILLE, NC 27560, UNITED STATES

Sector

Medical

Auditor

PricewaterhouseCoopers LLP

Share holders

54

Employees

170

Liquidia Corporation Common Stock Statistics

Valuation Measures

Market Capitalization2

1.21B

Enterprise Value

1.15B

Enterprise Value/EBITDA(ttm)

-9.64

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

89.46

Price to Book(mrq)

12.64

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

57.06%

Operating Margin(ttm)

-801.89%

Profit Margin(ttm)

-994.18%

Return on Equity(ttm)

-163.21%

Return on Invested Capital(ttm)

-134.92%

Return on Assets(ttm)

-67.14%

Income Statement

Revenue(ttm)

14.00M

Revenue Per Share(ttm)

0.16

Gross Profit(ttm)

8.12M

EBITDA(ttm)3

-119.10M

Net Income Available to Common(ttm)

-130.39M

Diluted EPS(ttm)

-1.63

Share Statistics

Beta (5Y Monthly)

0.27

52-Week Change

13.72%

S&P 500 52-Week Change

9.72%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

85.30M

Dividend Yield

0.00%

Float4

59.16M

% Held by Insiders

30.10%

% Held by Institutions

64.54%

Balance Sheet

Total Cash(mrq)

176.48M

Total Cash Per Share(mrq)

2.07

Total Debt(mrq)

115.39M

Total Debt/Equity(mrq)

149.32%

Current Ratio(mrq)

4.43%

Quick Ratio(mrq)

6.33%

Book Value Per Share(mrq)

0.91

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.19

Free Cash Flow(ytd)

-98.36M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement